Neeta D. Pandit
Advanced in Neuroendocrine Tumor

Dr. Neeta D. Pandit

Radiology
200 Lothrop Street, Suite 200, 
Pittsburgh, PA 
On Staff At
Advanced in Neuroendocrine Tumor
200 Lothrop Street, Suite 200, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Neeta Pandit-Taskar, MD, specializes in diagnostic radiology and nuclear medicine. She is affiliated with UPMC Bedford, UPMC Shadyside, and UPMC Presbyterian. Dr. Pandit-Taskar received her medical degree from Lady Hardinge Medical College and completed residencies at the University of Delhi and NYC Health + Hospitals/Elmhurst, followed by a fellowship at Memorial Sloan Kettering Cancer Center.

Dr. Pandit is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Adrenal Cancer, Neuroendocrine Tumor, Melorheostosis, Melorheostosis with Osteopoikilosis, and Orchiectomy.

Her clinical research consists of co-authoring 149 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 14 articles and participated in 1 clinical trial in the study of Neuroendocrine Tumor.

Graduate Institution
Lady Hardinge Medical College
Residency
University of Delhi
Specialties
Radiology
Licenses
Nuclear Medicine in PA
Fellowships
Memorial Sloan-Kettering Cancer Center
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Languages Spoken
English
Gujarati 
Hindi
Marathi
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 3 Less Insurance Carriers -

Locations

University of Pittsburgh Physicians, Department of Radiology
200 Lothrop Street, Suite 200, Pittsburgh, PA 15213
Other Locations
Hamot Radiology
201 State Street, Erie, PA 16550
UPMC Northwest Radiology
100 Fairfield Drive, Seneca, PA 16346
Fayette Oncology Associates
51 Brewer Drive, Uniontown, PA 15401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma: A Multi-center, Dose-escalation, Open-label, Non-randomized, Phase 1-2a Theranostic Clinical Trial
67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma: A Multi-center, Dose-escalation, Open-label, Non-randomized, Phase 1-2a Theranostic Clinical Trial
Enrollment Status: Terminated
Publish Date: September 16, 2025
Intervention Type: Drug
Study Drugs: 67Cu-SARTATE, 64Cu-SARTATE
Study Phase: Phase 1/Phase 2
A Phase I/IIA Study of 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
A Phase I/IIA Study of 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Radiation, Other, Device
Study Phase: Phase 1/Phase 2
Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Pilot Trial of PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer
Enrollment Status: Completed
Publish Date: December 10, 2024
Intervention Type: Radiation, Device
Study Phase: Not Applicable
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Diagnostic test
Study Phase: Phase 3
Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer
Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer
Enrollment Status: Completed
Publish Date: October 10, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase I Study of Positron Emission Tomography (PET/CT) With ⁸⁹Zr-Df-IAB22M2C in Patients With Selected Solid Malignancies (Non Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Squamous Cell Carcinoma Head and Neck (SqCCHN), Melanoma, Merkel Cell Tumor, Renal, Bladder, Hepatocellular, Triple Negative Breast, or Gastroesophageal Cancer) or Hodgkin's Lymphoma
A Phase I Study of Positron Emission Tomography (PET/CT) With ⁸⁹Zr-Df-IAB22M2C in Patients With Selected Solid Malignancies (Non Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Squamous Cell Carcinoma Head and Neck (SqCCHN), Melanoma, Merkel Cell Tumor, Renal, Bladder, Hepatocellular, Triple Negative Breast, or Gastroesophageal Cancer) or Hodgkin's Lymphoma
Enrollment Status: Completed
Publish Date: September 18, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

149 Total Publications

Pediatric PET/MRI: Imaging Techniques, Indications, and Clinical Implementation.
Pediatric PET/MRI: Imaging Techniques, Indications, and Clinical Implementation.
Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: October 16, 2025
Similar Doctors
Advanced in Neuroendocrine Tumor
Dr. Jitesh Dhingra
Nuclear Medicine | Radiology
Advanced in Neuroendocrine Tumor
Dr. Jitesh Dhingra
Nuclear Medicine | Radiology

Allegheny Clinic Radiology

100 S Jackson Ave, 
Pittsburgh, PA 
 (6.3 miles away)
412-734-6015
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jitesh Dhingra is a Nuclear Medicine specialist and a Radiologist in Pittsburgh, Pennsylvania. Dr. Dhingra is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Osteopenia, Melorheostosis with Osteopoikilosis, Melorheostosis, and Gastroesophageal Junction Cancer.

Experienced in Neuroendocrine Tumor
Dr. Athanasios T. Colonias
Radiation Oncology | Radiology
Experienced in Neuroendocrine Tumor
Dr. Athanasios T. Colonias
Radiation Oncology | Radiology

Allegheny Clinic

12311 Perry Hwy, 
Wexford, PA 
 (14.4 miles away)
412-359-3457
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Athanasios Colonias is a Radiation Oncologist and a Radiologist in Wexford, Pennsylvania. Dr. Colonias is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Pleuropulmonary Blastoma, and ALK-Positive Non-Small Cell Lung Cancer.

Experienced in Neuroendocrine Tumor
Dr. Joseph N. Agnesi
Radiology
Experienced in Neuroendocrine Tumor
Dr. Joseph N. Agnesi
Radiology

Cambria Somerset Radiology And Nuclear Medicine Group Inc

1086 Franklin St, 
Johnstown, PA 
 (55.7 miles away)
814-536-7226
Languages Spoken:
English
See accepted insurances

Joseph Agnesi is a Radiologist in Johnstown, Pennsylvania. Dr. Agnesi is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Osteopenia, Melorheostosis with Osteopoikilosis, Melorheostosis, and Thyroid Nodule.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pandit's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile